| __timestamp | Bio-Techne Corporation | Iovance Biotherapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 2704597 |
| Thursday, January 1, 2015 | 40853000 | 15470000 |
| Friday, January 1, 2016 | 45187000 | 28037000 |
| Sunday, January 1, 2017 | 53514000 | 71615000 |
| Monday, January 1, 2018 | 55329000 | 99828000 |
| Tuesday, January 1, 2019 | 62413000 | 166023000 |
| Wednesday, January 1, 2020 | 65192000 | 201727000 |
| Friday, January 1, 2021 | 70603000 | 259039000 |
| Saturday, January 1, 2022 | 87140000 | 294781000 |
| Sunday, January 1, 2023 | 92493000 | 344077000 |
| Monday, January 1, 2024 | 96664000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Bio-Techne Corporation and Iovance Biotherapeutics, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Bio-Techne's R&D expenses grew steadily, increasing by approximately 212%, reflecting a consistent commitment to innovation. In contrast, Iovance Biotherapeutics, Inc. exhibited a more aggressive strategy, with R&D spending skyrocketing by over 12,600% during the same period, peaking in 2023. This surge underscores Iovance's focus on pioneering breakthroughs in cancer immunotherapy. However, data for 2024 is incomplete, highlighting the dynamic nature of financial planning in biotech. As these companies continue to navigate the evolving landscape, their R&D investments will likely play a pivotal role in shaping their future trajectories.
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
Research and Development Expenses Breakdown: Takeda Pharmaceutical Company Limited vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Incyte Corporation and Iovance Biotherapeutics, Inc.
Dr. Reddy's Laboratories Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Bio-Techne Corporation or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Analyzing R&D Budgets: Bio-Techne Corporation vs Arrowhead Pharmaceuticals, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Amphastar Pharmaceuticals, Inc.
Mesoblast Limited or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?